Literature DB >> 18776149

Longitudinal decline in lung volume in a population of children with sickle cell disease.

Joanna E MacLean1, Eshetu Atenafu, Melanie Kirby-Allen, Ian B MacLusky, Derek Stephens, Hartmut Grasemann, Padmaja Subbarao.   

Abstract

RATIONALE: Sickle cell disease (SCD) results in significant morbidity and mortality attributable to pulmonary complications. The pattern of lung function change across childhood in SCD is not well delineated.
OBJECTIVES: To determine if the pattern of lung function in SCD differs from race-matched, predicted values across childhood, to describe that pattern of change, and to examine the effect of clinical covariates on lung function.
METHODS: Lung function measurements for children with SCD, aged 8-18 years, from a single center were examined for inclusion. Mixed-model analysis was used to retrospectively review lung function in these children in comparison with those predicted by race-matched reference equations. The contribution of age, sex, Hb level, and beta-globin genotype on longitudinal changes in lung function was examined.
MEASUREMENTS AND MAIN RESULTS: Children with SCD show significant decline in spirometric lung volumes across childhood that are concordant with the pattern of change in other measures of lung volume. The average decline for FEV(1) and total lung capacity is 2.93 and 2.15% predicted/year for males and 2.95 and 2.43% predicted/year for females. beta-Globin genotypes known to be associated with more severe disease showed a faster decline in lung function, whereas sex showed an inconsistent effect on lung function.
CONCLUSIONS: Lung volumes in children with SCD decline with age. The pattern of decline begins in childhood, and supports a predominately restrictive defect.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18776149     DOI: 10.1164/rccm.200708-1219OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  19 in total

1.  The impact of recurrent acute chest syndrome on the lung function of young adults with sickle cell disease.

Authors:  Jennifer M Knight-Madden; Terrence S Forrester; Norma A Lewis; Anne Greenough
Journal:  Lung       Date:  2010-07-20       Impact factor: 2.584

2.  ATS Core Curriculum 2016: Part III. Pediatric Pulmonary Medicine.

Authors:  Debra Boyer; Carey C Thomson; Robyn Cohen; Devika Rao; Sharon Dell; Jonathan Rayment; Ruobing Wang; Fei J Dy; Jennifer Wambach; Jade Tam-Williams; Dawn Simon; Eric Price; Christopher M Oermann; Alvin Singh; Jordan S Rettig; Elizabeth D Duncan; Christopher D Baker; Deborah R Liptzin; Paul E Moore
Journal:  Ann Am Thorac Soc       Date:  2016-06

3.  Interpretation of pediatric lung function: impact of ethnicity.

Authors:  J Kirkby; R Bonner; S Lum; P Bates; V Morgan; R C Strunk; F Kirkham; S Sonnappa; J Stocks
Journal:  Pediatr Pulmonol       Date:  2012-03-19

4.  Age is a predictor of a small decrease in lung function in children with sickle cell anemia.

Authors:  Shaina M Willen; Robyn Cohen; Mark Rodeghier; Fenella Kirkham; Susan S Redline; Carol Rosen; Jane Kirkby; Michael R DeBaun
Journal:  Am J Hematol       Date:  2018-01-25       Impact factor: 10.047

5.  Pattern of Lung Function Is Not Associated with Prior or Future Morbidity in Children with Sickle Cell Anemia.

Authors:  Robyn T Cohen; Robert C Strunk; Mark Rodeghier; Carol L Rosen; Fenella Jane Kirkham; Jane Kirkby; Michael R DeBaun
Journal:  Ann Am Thorac Soc       Date:  2016-08

6.  Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease.

Authors:  Mark C Walters; Karen Hardy; Sandie Edwards; Thomas Adamkiewicz; James Barkovich; Francoise Bernaudin; George R Buchanan; Nancy Bunin; Roswitha Dickerhoff; Roger Giller; Paul R Haut; John Horan; Lewis L Hsu; Naynesh Kamani; John E Levine; David Margolis; Kwaku Ohene-Frempong; Melinda Patience; Rupa Redding-Lallinger; Irene A G Roberts; Zora R Rogers; Jean E Sanders; J Paul Scott; Keith M Sullivan
Journal:  Biol Blood Marrow Transplant       Date:  2009-10-12       Impact factor: 5.742

7.  Unraveling restrictive chronic lung disease in sickle cell disease.

Authors:  Shilpa Jain; Mark T Gladwin; Enrico M Novelli
Journal:  Int J Tuberc Lung Dis       Date:  2013-09       Impact factor: 2.373

8.  American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease.

Authors:  Robert I Liem; Sophie Lanzkron; Thomas D Coates; Laura DeCastro; Ankit A Desai; Kenneth I Ataga; Robyn T Cohen; Johnson Haynes; Ifeyinwa Osunkwo; Jeffrey D Lebensburger; James P Lash; Theodore Wun; Madeleine Verhovsek; Elodie Ontala; Rae Blaylark; Fares Alahdab; Abdulrahman Katabi; Reem A Mustafa
Journal:  Blood Adv       Date:  2019-12-10

9.  Abnormal pulmonary function and associated risk factors in children and adolescents with sickle cell anemia.

Authors:  Manuel Arteta; Andrew Campbell; Mehdi Nouraie; Sohail Rana; Onyinye C Onyekwere; Gregory Ensing; Craig Sable; Niti Dham; Deepika Darbari; Lori Luchtman-Jones; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro; Caterina P Minniti; Victor R Gordeuk
Journal:  J Pediatr Hematol Oncol       Date:  2014-04       Impact factor: 1.289

10.  Progression and prognostic indicators of bronchial disease in children with sickle cell disease.

Authors:  Sophia N Williams; Eliezer Nussbaum; Leila Yoonessi; Tricia Morphew; Inderpal Randhawa
Journal:  Lung       Date:  2014-04-04       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.